The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)

Kathryn Richardson1, Blossom C M Stephan, Paul G Ince

  • 1The Irish Longitudinal Study on Ageing, Department of Medical Gerontology, Trinity College Dublin, Dublin, Ireland. richarkj@tcd.ie

Insights

Vascular risk factors like stroke and heart attack were linked to brain microinfarcts, not Alzheimer's pathology. Improving cardiovascular health may prevent cognitive decline.

Area of Science:

  • Neurology
  • Gerontology
  • Pathology

Background:

  • Vascular disease is a known risk factor for dementia.
  • Vascular health naturally declines with aging.
  • This study examines the link between self-reported vascular conditions and brain pathology.

Purpose of the Study:

  • To investigate the relationship between self-reported vascular disease and specific brain pathologies.
  • To determine if common vascular conditions are associated with Alzheimer's disease pathology or cerebrovascular changes.
  • To explore the connection between cardiovascular health and neuropathological markers in older adults.

Main Methods:

  • Utilized brain donations from the population-based MRC Cognitive Function and Ageing Study (n=456, aged 66-103).
  • Assessed Alzheimer's disease (AD) and cerebrovascular pathology using a standard protocol.
  • Identified vascular conditions (stroke, angina, diabetes, hypertension, heart attack) from medical records and interviews; analyzed associations using logistic regression.

Main Results:

  • Stroke was associated with vascular pathology but not AD pathology.
  • Medicated hypertension correlated with increased microinfarcts and less severe neocortical tangles and cerebral amyloid angiopathy.
  • Heart attack was linked to a higher incidence of microinfarcts.

Conclusions:

  • Vascular risk factors were not associated with increased Alzheimer's disease pathology in older age.
  • Systemic cardiovascular health indicators (hypertension, ischemic heart disease) showed a positive association with cerebral microinfarcts.
  • Findings suggest cerebral small vessel disease and cardiovascular disease are interrelated, highlighting microinfarcts as key in vascular cognitive impairment and supporting cardiovascular health improvement for cognitive protection.
Abstract

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...